IHS Customer Logins

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.

Top Sites

Life Sciences Consulting

Advance your company’s footprint

Looking to price a new drug? Enter an emerging market?

We provide customized healthcare market analysis, reimbursement consulting and regulation solutions, pricing models, market entry strategies and single or multi-client studies to help you:

  • Size and seize market opportunities
  • Drive operational efficiencies and ROI
  • Optimize product and sales strategies
  • Evaluate the economic impact of business or policy decisions
  • Respond quickly to alternative outcomes and shocks

Advisory Services

Market Research
Demonstrate the potential of pharmaceuticals, biotechnology products, medical devices and care delivery patterns on patient health outcomes, medical costs, productivity and quality of life

Reimbursement Consulting
Identify and quantify key cost drivers to develop efficient, evidence-based estimates for reimbursement and prospective payment

Healthcare Pricing Models
Develop the optimal new drug price and market entry strategy

Market Entry Analysis
Receive continuous analysis, data and online tools covering technology, reimbursement, regulations, geographic/therapeutic segment scenarios

Single-Client Reports
Partner with us for customized research on business improvement and opportunity maximization strategies

Multi-Client Reports
Access customized research at less cost by participating in multi-client, syndicated market research that employs qualitative and quantitative surveys, market access scenarios and market analysis

Recent Projects

Integrating HTA Requirements into Oncology R&D Process

A pharmaceutical company needed recommendations for incorporating more HTA considerations into R&D decision-making.

We researched recent HTA decisions in Australia, US, United Kingdom, France, Germany, Italy and Spain in the client’s four therapeutic areas. Our detailed case studies identified the choice of trial design, trial comparator, patient group selection, primary and secondary outcome measures, strength of correlation between surrogate and final outcomes, traits of PRO evidence and studies, and a definition of clinical relevance.

We helped the client build user-friendly HTA "checklists". The client uses these checklists to ensure its R&D personnel factor HTA considerations into future planning.

Industry Success Stories

Blog Feed

Aug 25

Our burgeoning understanding of payer perspectives on relative effectiveness

We’ve been reading, with interest, a new report just released by the UK Office of Health Economics (OHE) in partnership with the US Center for Medical Technology Policy (CMTP) on payer perspective over comparative and relative effectiveness. The study joins together with other research in this area to reinforce our underst..more

Aug 19

Impact of the Tianjin explosion on the global pharmaceutical industry

The largest of several explosions, which were unleashed in a warehouse last week in China’s port city of Tianjin, packed the same amount of firepower as 21 tonnes of TNT. Although the blasts occurred in an area home mainly to logistics firms, several pharmaceutical companies also have operations within the 2-kilometer radius of d..more

Twitter Feed

Aug 27

Diabetes Foreningen publishes major impact study on diabetes related costs in Denmark http://t.co/vXlPKIMIU0


Filter Sort